Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep-Oct;22(5):632-635.
doi: 10.4103/ijem.IJEM_11_18.

Effect of Glycemic Variability on Mortality in ICU Settings: A Prospective Observational Study

Manjitpal Singh  1 , Vimal Upreti  2 , Yashpal Singh  2 , Anand S Kannapur  3 , Monish Nakra  3 , Narendra Kotwal  1
Affiliations

Effect of Glycemic Variability on Mortality in ICU Settings: A Prospective Observational Study

Manjitpal Singh et al. Indian J Endocrinol Metab. 2018 Sep-Oct.

Abstract

Background: Evidence suggests a role of glycemic variability in intensive care unit (ICU) mortality.

Objective: To assess effect of glycemic variability and ICU/in-hospital mortality.

Design: Prospective, observational study.

Setting: A 20-bedded medical/surgical ICU in a tertiary care hospital.

Patients: Critically ill patients requiring life-support measures admitted to the ICU between November 1, 2015 and December 30, 2016 with hyperglycemia [random blood sugar (RBS) ≥200 mg%] and sequential organ failure assessment (SOFA) scores ≤9. Patients were put on predefined insulin infusion protocol, multiple glucose values were obtained, and mean blood glucose level (MGL) was calculated as their simple arithmetic mean. Standard deviation (SD) of MGL and coefficient of variation (CV) of glucose (derived as a percentage of SD to mean blood glucose) were then calculated for each patient and analyzed for all-cause death during hospitalization period.

Results: A total of 123 patients having a mean age of 65.12 ± 16.27 years, mean SOFA score of 5.76 ± 1.76, and mean HbA1c of 6.22 ± 0.73% were included. MGL was 160.65 ± 24.19 mg/dl, SD 33.32 ± 15.08 mg/dl, and CV 20.74 ± 8.43. Deceased as compared to survivors had higher MGL (163.76 ± 24.85 vs 155.62 ± 22.43 mg/dl, P = 0.068) and higher glycemic variability (SD 38.92 ± 14.44 vs 25.06 ± 12.27 mg/dl; P < 0.001 and CV 23.69 ± 7.9 vs 15.98 ± 6.87; P < 0.001). Interestingly, more patients having higher CV at lower MGL (85.7%) died as compared to those having lower CV at higher MGL (55.6%).

Conclusions: High glycemic variability is associated with increased ICU/in-hospital mortality. Outcome of patients having less glycemic variability even with slight hyperglycemia may be better than those having tight glycemic control but higher glycemic variability. Insulin protocols need to be in place for management of hyperglycemia in critical care setting aiming for adequate glycemic control as well as minimizing glycemic variability.

Keywords: Coefficient of variation of glucose; glycemic variability; mean blood glucose.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Age distribution of patients at baseline and deceased patients
See this image and copyright information in PMC

References

    1. American Diabetes Association. Standards of Medical Care in Diabetes—2017: Summary of Revisions. Diabetes Care. 2017;40:S4–5. - PubMed
    1. van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical intensive care unit. N Engl J Med. 2006;354:449–61. - PubMed
    1. Kong MY, Alten J, Tofil N. Is hyperglycemia really harmful? A critical appraisal of “Persistent hyperglycemia in critically ill children” by Faustino and Apkon (J Pediatr 2005;146:30-34) Pediatr Crit Care Med. 2007;8:482–5. - PubMed
    1. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67. - PubMed
    1. Malmberg K. Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997;314:1512–5. - PMC - PubMed